Blaze Medical Devices, Inc.
Biotechnology ResearchMichigan, United States2-10 Employees
Blaze Medical Devices is a company that successfully developed technology for profiling the mechanical fragility (MF) of red blood cells (RBC) to help characterize RBC health/damage in various contexts. In 2018, Blaze licensed out its intellectual property to Detroit-based Functional Fluidics, which then began offering a RBC MF test alongside its other assays. Prior to 2018, Blaze had operated actively as a biomedical startup in Ann Arbor, Michigan. Since then, the entity's ongoing IP licensing is overseen by its board members Michael Tarasev and Kenneth Alfano.